Mapping of nanobody binding sites on human LRRK2 by CX-MS
Ontology highlight
ABSTRACT: As part of an in-depth characterization of nanobodies directed against the human Leucine-rich repeat kinase 2 (LRRK2), epitopes of the nanobodies bound to LRRK2 were mapped by chemical crosslinking combined with mass spectrometry using the CID-cleavable crosslinker disuccinimidyl sulfoxide (DSSO).
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
DISEASE(S): Parkinson's Disease
SUBMITTER:
Christian Johannes Gloeckner
LAB HEAD: Christian Johannes Gloeckner
PROVIDER: PXD030063 | Pride | 2022-02-27
REPOSITORIES: Pride
ACCESS DATA